Category "Okategoriserade"

ISAB’s exhibitor hosted session ’XposeALI: Setting a New Standard for ALI Cell Exposures’, with CSO Per Gerde,  is at the Society Of Toxicology (SOT) Annual Meeting, New Orleans,…

ISAB’s exhibitor hosted session ’XposeALI: Setting a New Standard for ALI Cell Exposures’, with CSO Per Gerde,  is at the Society Of Toxicology (SOT) Annual Meeting, New Orleans,…

King’s College Institute of Pharmaceutical Science is purchasing ISAB’s PreciseInhale® system to strengthen its capabilities in respiratory research. ISAB CEO Fredrik Sjövall: “We’re delighted to deepen our relationship…

King’s College Institute of Pharmaceutical Science is purchasing ISAB’s PreciseInhale® system to strengthen its capabilities in respiratory research. ISAB CEO Fredrik Sjövall: “We’re delighted to deepen our relationship…

The patent for DissolvIt, ISAB’s in vitro simulation technology, has been approved by the EPO (European Patent Office). “Establishing in vitro data early on can save companies developing…

The patent for DissolvIt, ISAB’s in vitro simulation technology, has been approved by the EPO (European Patent Office). “Establishing in vitro data early on can save companies developing…

At DDL 26 (Drug Delivery to the Lungs) in Edinburgh, December 9-11, ISAB will present a poster on In Vitro-Ex Vivo research carried out with Karolinska Institutet: In Vitro –…

At DDL 26 (Drug Delivery to the Lungs) in Edinburgh, December 9-11, ISAB will present a poster on In Vitro-Ex Vivo research carried out with Karolinska Institutet: In Vitro –…

An ambitious, four-year research collaboration on in vitro dissolution, carried out by Hovione, ISAB, and the University of Lisbon’s Faculdade de Farmácia, will significantly deepen understanding of the…

An ambitious, four-year research collaboration on in vitro dissolution, carried out by Hovione, ISAB, and the University of Lisbon’s Faculdade de Farmácia, will significantly deepen understanding of the…